Powered by its artificial intelligence software platform, the nference mission is to synthesize the exponentially growing biomedical knowledge. nference uses state-of-the-art neural networks (shallow and deep learning models) for real-time, automated extraction of knowledge from the scientific, regulatory and commercial body of literature. The platform enables a diverse set of applications ranging from R&D to commercial strategy and operations in the life sciences ecosystem. nference is making biomedical knowledge computable, and building its AI platform to serve as the connective fabric for various silos of information that exist across health care enterprises. Founded by Murali Aravamudan and Venky Soundararajan, Ph.D., nference is led by a multidisciplinary team of serial entrepreneurs from the tech and biotech worlds and Ph.D.s in Biology/Genomics from Massachusetts Institute of Technology (MIT) and Harvard Medical School.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/06/18 | $11,000,000 | Series A |
Matrix Capital Management Matrix Partners  | undisclosed |
| 01/08/20 | $60,000,000 | Series B |
Mayo Clinic Ventures | undisclosed |
| 12/15/20 | $60,000,000 | Series C |
Matrix Capital Management Matrix Partners Mayo Clinic Ventures NTT Venture Capital | undisclosed |
